US Patent Issued to Gambro Lundia on June 24 for "Apparatus and method for controlling infusion rate of pre- and post-dilution in extracorporeal blood treatment" (Swedish Inventor)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,086, issued on June 24, was assigned to Gambro Lundia AB (Lund, Sweden).

"Apparatus and method for controlling infusion rate of pre- and post-dilution in extracorporeal blood treatment" was invented by Jan Sternby (Lund, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "An apparatus (1a) for extracorporeal blood treatment, comprising an infusion control arrangement (8) arranged for infusing a pre-dilution flow rate upstream a blood treatment unit (4) and a post-dilution flow rate downstream the blood treatment unit (4), an ultrafiltration, UF, arrangement (40) arranged for ultrafiltration of a liquid through a semipermeable membrane (7) of the b...